Health Care & Life Sciences » Pharmaceuticals | Chongqing Lummy Pharmaceutical Co. Ltd.

Chongqing Lummy Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
754
908
958
978
1,262
1,534
Cost of Goods Sold (COGS) incl. D&A
498
658
652
638
720
682
Gross Income
256
250
306
340
543
852
SG&A Expense
170
191
216
249
462
730
EBIT
81
55
82
82
77
117
Unusual Expense
-
-
-
58
22
10
Non Operating Income/Expense
5
4
2
14
10
60
Interest Expense
33
51
61
33
38
60
Pretax Income
75
6
26
13
29
113
Income Tax
12
5
5
3
2
18
Equity in Affiliates
-
-
1
9
19
3
Consolidated Net Income
63
11
20
1
46
91
Net Income
61
9
21
7
56
98
Net Income After Extraordinaries
61
9
21
7
56
98
Net Income Available to Common
61
9
21
7
56
98
EPS (Basic)
0.09
0.01
0.03
0.01
0.07
0.12
Basic Shares Outstanding
676
726
742
812
812
812
EPS (Diluted)
0.09
0.01
0.03
0.01
0.07
0.12
Diluted Shares Outstanding
676
726
742
812
812
812
EBITDA
134
136
191
192
190
225
Other Operating Expense
5
4
8
10
3
4
Non-Operating Interest Income
7
5
3
2
2
2
Minority Interest Expense
2
2
-
6
9
7

About Chongqing Lummy Pharmaceutical Co.

View Profile
Address
15th Floor, Tower B
Chongqing Chongqing 401123
China
Employees -
Website http://www.cqlummy.com
Updated 07/08/2019
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.